Zogenix reported $0 in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acura Pharmaceuticals ACUR:US 651K 430K
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
AstraZeneca AZN:LN 387M 59M
Biogen BIIB:US $ 0.1M 0M
Cardinal Health CAH:US 2.67B 140M
Esperion Therapeutics ESPR:US $ 27K 1000
Flexion Therapeutics FLXN:US $ 50K 0
GlaxoSmithKline GSK:LN 1347M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Teva Pharmaceutical TEVA:IT 57M 0